---  
layout: startup_page  
title: "Immunis"  
id: "immunisbiomedical.com"  
permalink: "/immunisimmunisbiomedical.com01112025/"  
website: "https://immunisbiomedical.com"  
funding_round: "Series A1"  
funding_amount: "$25M"  
investors: "Remiges Ventures, Continuum Health Ventures, BOLD Capital Partners, LifeSpan Vision Ventures, JLS Fund"  
about: "Immunis, Inc. is a clinical-stage biotech company developing multi-active biologics to address age and disease-related immune dysregulation. Their lead product, IMM01-STEM, is in Phase 2 clinical trials for muscle loss and metabolic dysfunction, showing promising results in improving quality of life and physical function in elderly patients. The company leverages cutting-edge multi-active secretome technology."  
markets: "Biotechnology, Healthtech, Therapeutics"  
hq: "Irvine, California, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/immunisbiomedical"  
twitter: ""  
instagram: ""  
facebook: "https://www.facebook.com/ImmunisBio"  
crunchbase: "https://www.crunchbase.com/organization/immunis"  
pitchbook: ""  

date_display: "11-Jan-2025"  
date: "2025-01-11"

# SEO Optimization  
meta_title: "Immunis - Series A1 Funding ($25M)"  
meta_description: "Immunis, Immunis, Inc. is a clinical-stage biotech company developing multi-active biologics to address age and disease-related immune dysregulation. Their lea..."  
meta_keywords: "Immunis, Biotechnology, Healthtech, Therapeutics, Series A1 funding"  
canonical_url: "https://startup.projectstartups.com/immunisimmunisbiomedical.com01112025/"  
---